Evidence map›Paper›PMID 32646918›Full record

ArticleThe European respiratory journal2020

The associations of interstitial lung abnormalities with cancer diagnoses and mortality.

Gisli T Axelsson, Rachel K Putman, Thor Aspelund, Elias F Gudmundsson, Tomayuki Hida, Tetsuro Araki, Mizuki Nishino, Hiroto Hatabu, Vilmundur Gudnason, Gary M Hunninghake and 1 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The European respiratory journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05986318 (Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease), which is not on this map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05986318 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease: A 2x2 Factorial Randomized Phase II Trial Testing N-Acetyl Cysteine and Dexamethasone

TypeinterventionalSponsorDavid PalmaRan2025 to 2032Enrolled98ConditionsLung Cancer, Interstitial Lung DiseaseArmsN-Acetyl cysteine, Dexamethasone Oral, N-Acetyl cysteine Placebo, Dexamethasone Placebo, Radiation Therapy
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Gisli T AxelssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland gtha7@hi.is.
Rachel K PutmanPulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Thor AspelundFaculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0002-7998-5433
Elias F GudmundssonIcelandic Heart Association, Kopavogur, Iceland.ORCID 0000-0002-7661-4872
Tomayuki HidaDept of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tetsuro ArakiDept of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-0440-6078
Mizuki NishinoDept of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Hiroto HatabuDept of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1436-2988
Vilmundur GudnasonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Gary M HunninghakePulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Gunnar GudmundssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Brigham and Women's Hospital · USUniversity of Iceland · ISIcelandic Heart Association · ISReykjavík University · IS

Funding

Clinical Genetics and Screening for Pulmonary FibrosisR01HL130974 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GARY MATTHEW HUNNINGHAKE, Benjamin Alexander Raby · 2016 to 2026
$10.0M
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung AbnormalitiesR01HL135142 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL H. CHO, GARY MATTHEW HUNNINGHAKE · 2017 to 2026
$7.7M
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.R01HL111024 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNNINGHAKE, GARY MATTHEW · 2013 to 2022
$6.4M
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatmentR01CA203636 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI NISHINO, MIZUKI · 2017 to 2021
$2.9M
Progression of interstitial lung abnormalities: the role of imaging and telomere length regulationK08HL140087 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI PUTMAN, RACHEL · 2018 to 2022
$852k
NCI NIH HHS R01 CA203636NHLBI NIH HHS K08 HL140087NHLBI NIH HHS R01 HL111024NHLBI NIH HHS R01 HL130974NHLBI NIH HHS R01 HL135142
6 · The paper itself

Abstract

An increased incidence of lung cancer is well known among patients with idiopathic pulmonary fibrosis. It is not known whether interstitial lung abnormalities,

Indexed as

Lung NeoplasmsAdultEarly Detection of CancerHumansIcelandLungProportional Hazards ModelsTomography, X-Ray Computed

Identifiers

PMID32646918
PMCPMC7876778
OpenAlexW3041552326

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.